MRI-guided radiation for certain prostate cancer risks
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18
- You have prostate cancer confirmed by biopsy as adenocarcinoma
- Your cancer is in a specific risk group (low, favorable intermediate, unfavorable intermediate, or limited high risk)
- Your general health is good (performance score 0–2) and you can consent in writing
- Your prostate symptoms are not too severe (IPSS 19 or lower)
- You can have an MRI (no MRI contraindications) and you have not had pelvic radiation before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This study tests a precise radiation treatment for prostate cancer that uses MRI images to guide the radiation beams. It may be an option for men with higher-risk prostate cancer who can have an MRI and have not had radiation before.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.